September 09, 2010 11:23 ET

Ramon Richard Is Named President and CEO of Grupo Intl Inc. Formerly HIV-VAC, Inc.

TORONTO--(Marketwire - September 9, 2010) -  Kevin Murray, President of HIV-VAC, Inc. (PINKSHEETS: HIVV), announced today that the Board of Directors has elected Mr. Ramon Richard as the new President, CEO and a Director of the Company, effective immediately. Mr. Murray will remain a director of the Company, has agreed to act has CFO and will also head the Pharmaceutical Division. In addition, the company has received majority shareholder approval to effect a name change from "HIV-VAC, Inc." to Grupo International Inc. in order to better reflect its direction and businesses, and expects to file the name change with the state of Nevada in the next few days. 

Mr. Richard has notified the Board that they have engaged "Gossler, S.C.," one of the largest and oldest accounting firms in all of Mexico, to complete the audit of Richard y Lange by the first week of October. This audit will coincide with the year end audit of "HIV-VAC, Inc." The Company will then begin filing its past annual and quarterly filings in order to comply with the SEC requirements for reporting companies.

The Company looks forward to its new direction and excellent management. Mr. Richard plans to call a Board meeting in the immediate future in order to nominate another Director. 


Richard Y Lange S.A. De C.V. recently entered into its final binding agreement with HIV-VAC, Inc. on August 25, 2010. As part of the restructure, the Company agreed to change its direction and is in the process of changing its symbol so that it will better reflect its international standing and direction. The Company operates two divisions. HIV-VAC continues its development of vaccines while at the same time, Grupo International will expand the International business of "Richard y Lange." The "Richard y Lange" Division is operating under the names of "RiMart," which presently operates 14 tool retail stores throughout Baja California, "GR Construction," specializing in large industrial projects, "Block GRYLSA" which operates block manufacturing facilities, and GRYLSA's raw materials division that mines commercial grade sand located near the border of the State of California and Baja California. The management will continue to operate each division separately while reporting directly to the President, CEO, and the Board of Directors.

Safe Harbor:
The information contained in this press release, including any "forward looking" statements within the meaning of section 27A of the securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the Company's Annual Report on Form 10-KSB and other publicly available information regarding the Company, copies of which are available from the Company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business and such statements, including risks and uncertainties related to that are unpredictable and outside of the influence and/or control of the Company. In particular, these risks and uncertainties include, without limitation: that third parties may be successful in challenging the patent issued; that granted claims may be held invalid or interpreted differently by a court of law; that other patents will issue that will block the Company from commercializing the technology covered by the patents; and that the benefits that Company believes can be derived from the patented technology will not be realized due to difficulties encountered in the long and expensive process of the development of new technologies and the cost and uncertainty in obtaining regulatory approval for products based on these technologies. In addition, there are many other risks and uncertainties inherent in the development of the Company's products, including the risk of not obtaining regulatory approval for a variety of reasons and the risk of adverse side effects in humans. Other risks relating to Company are detailed from time to time in documents filed by Company with the SEC.

Contact Information

    HIV-VAC, Inc.
    Kevin W. Murray
    12 Harben Court
    Collingwood, Ontario, Canada L9Y 4L8
    Tel: (705) 444-6317

    For more information please check the Company's information or web site below.
    Web Site:
    Investor Relations:
    Contact Number: 702-952-3998